Dr. Genevieve M. Boland, MD, PhD

Dr. Boland practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Boland's NPI, 1699801019, was assigned on February 27, 2007. Dr. Boland holds Massachusetts license 259762.

Dr. Boland's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Boland's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Boland is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Boland to 1 more hospital, 2 medical groups, 1 community health center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boland practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Boland's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Boland's licenses on file in 2 states: Massachusetts and Texas.

CMS data shows 73 Medicare services from Dr. Boland across 3 procedure codes in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $4,577 for them.

CMS counts 58 Medicare patients who saw Dr. Boland in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boland's median patient age at 73, with 46% women.

Dr. Boland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boland as offering telehealth. CMS counts 37 procedures of melanoma (skin cancer) excision by Dr. Boland, more than 83% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 167 papers to Dr. Boland, published from 2012 to 2025. 2020 was the busiest year, with 24. The most frequent topics are Melanoma, Immunotherapy and Skin Neoplasms. Dr. Boland has published most often in Ann Surg Oncol. Dr. Boland's most frequent co-authors are Giorgos Constantine Karakousis, MD, Sonia Cohen, MD, PhD and Donald Peter Lawrence, MD.

Dmand AI links Dr. Boland to 1 clinical trial. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 47 general payments to Dr. Boland from 6 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $35,309.